The key findings in this descriptive retrospective study of injury cost and incidence in the United States are that there is considerable heterogeneity in the trends of injury outcomes (i.e. fatal, non-fatal) and specific injury types (i.e. unintentional falls, firearm suicides). In the fatal injury category, unintentional drug poisoning, the top injury type in both incidence (99.6k fatalities) and cost ($1.13T total cost), rose in cost a striking 123% from 2015 levels. In both the non-fatal hospitalization and release and non-fatal ED and release categories, unintentional falls accounted for the greatest costs and incidence by wide margins. Total costs in the fatal and non-fatal outcome categories were dominated by non-medical costs, including value of statistical life, quality of life, and work losses. The average costs of the top ten fatal and non-fatal hospitalization and release injuries rose 28% and 26% during the 8-year study period, respectively, despite the United States population growing just 3.9% from 2015 to 2022(30).
Fatal Injuries
The fatal injury category displayed the highest average growth rate in total cost of any outcome studied at + 28% from 2015–2022. Total costs of unintentional drug poisonings in 2022 were more than twice that of the next most costly fatal injury (unintentional motor vehicle injuries) and increased 123% in total costs during this period, which was the highest of any injury type studied. Firearm-related suicides and homicides were the next most costly fatal injuries, with firearm homicides displaying the second-highest cost increase from 2015 at + 54%. All of the top three costliest fatal injury types grew at rates substantially higher than the United States population growth during the study period despite stability or decrease in per-injury costs, highlighting increased incidence as the key driver of fatal injury costs(30).
Unintentional drug poisonings, specifically fatal overdoses, are a recognized public health crisis in the United States(7, 31, 32, 33, 34). Incremental change in federal and state drug policies have struggled to address illicit substance use(33), with the continuation and exacerbation of overdose-related fatalities also largely due to increased usage of synthetic opioids(34). Per an analysis of drug overdose mortality among people experiencing homelessness by Fine et al, 2022, initial predominance of prescription opioids as the leading cause of fatal overdose in the early 21st -century was soon eclipsed by illicitly manufactured fentanyl and polysubstance overdose(31). Friedman et al, 2022 studied the demographics of drug overdose in the United States from 2010–2021 and found that beginning in 2020, adolescents experienced a greater relative increase in overdose mortality than the overall population despite nationally decreasing adolescent drug use rates, again potentially attributable to the ubiquity and increased potency of synthetic opioids(7). Regarding escalating polysubstance abuse, the rate of drug overdose deaths involving both cocaine and opioids increased more quickly from 2011–2021 than the rate of cocaine-only overdose deaths(35). Recent discussion in the substance abuse space warns of a potential “fourth wave” of the opioid overdose crisis marked by co-ingestion of fentanyl alongside methamphetamine and/or cocaine(36).
Motor vehicle crashes had just under half as many fatalities in 2022 as unintentional drug poisoning and increased in total costs by 22% from 2015. Fatal motor vehicle crashes are nearly three times more common in males and are the leading cause of fatal work-related injury in the United States(37, 38, 39). Historically, fatal motor vehicle injury were either stable or declining from 1999–2010, with a subsequent increase in fatality rates from 2010–2019(40, 41). Interestingly, this recent bump diverges considerably from the fatality trends of comparable Organization of Economic Cooperation and Development (OECD) countries, with the United States fatality rates per one million residents more than twice as high Canada, Australia, and the United Kingdom in 2021(42, 43). Despite improvements in pre-hospital care greatly enhancing crash survivability in recent years(44), reasons behind the increase in fatality rates are hypothesized to be multifactorial(45, 46). Yellman et al, 2022 posits looser blood alcohol concentration driving allowances relative to peer countries, inconsistent restraint use, and distracted driving as key sources of international discrepancies and rising US fatality rates(45). A meta-analysis of the impact of cannabis legality on motor vehicle accident deaths by Marinello et al, 2023 displayed a 10% increase in fatalities in states with legal recreational cannabis markets(46). However, conflicting research demonstrates an opposite trend due to substitution effects away from alcohol consumption(47), and studies into the trend inflection of motor vehicle fatalities remain nascent and challenging(48, 49, 50). The findings in this study diverge from sentiment around decreased motor vehicle fatalities constituting one of the greatest public health achievements of the 20th century(51, 52).
Total costs of suicide by firearm grew at a similar rate to unintentional motor vehicle fatalities (+ 21%). The link between firearm access and suicide completion is well-established(53, 54, 55). However, recent increases in incidence and total costs are alarming and complex, and are thought to stem from legal, mental health, and socioeconomic factors(56, 57, 58). Per Martínez-Alés et al, 2021, state-level ownership rates largely explain differences in firearm suicide but only marginally explain the recent increases in firearm suicide rates(58). Background checks and mandatory waiting periods, which have been slow to gain legislative traction, are correlated with lower firearm suicide risk(56). Multiple studies have shown increases in firearm suicide mortality risk among younger birth cohorts, in line with research detailing concurrent increases in depression and suicidal behaviors among US adolescents(57, 59, 60). Suicide is the leading cause of death in teenagers in the US, with nearly 50% of suicides completed by 15–19 year-olds involving a firearm(57). In addition to rising adolescent firearm suicide rates, a second spike in mortality is being observed in the elderly, specifically “Baby Boomer” males > 64 years old(59, 61). Finally, ethnic minorities–specifically those of American Indian descent–and counties with higher poverty rates continue to experience the highest and fastest-growing firearm suicide rates(62, 63).
Non-fatal Injuries
The non-fatal outcome categories–hospitalization and release (1) and ED and release (2)–were both dominated in incidence and total costs by unintentional falls, with total costs that increased 35% and 14% from 2015 levels, respectively. The 2022 incidence of unintentional falls requiring hospitalization and release was 1.70M, with medical costs of $91.5B ($53.9k per injury). Unintentional falls with an ED and release outcome were associated with a 2022 incidence of 6.57M and medical costs of $58.3B ($8.9k per injury). Gross medical costs in both non-fatal categories far exceeded those displayed by any of the top fatal injuries as well as fatal unintentional falls, which had medical costs of $1.76B ($37.8k per fatality).
The exceptional costliness and accompanying rise in unintentional fall costs (overall and per-injury) and incidence relative to US population growth, particularly for falls requiring hospitalization, is alarming. Considerable public health and healthcare economics research has been performed on fall injuries, prevention, and management(18, 64, 65, 66, 67). Per Colón-Emeric et al, 2024, fall mortality has more than doubled in the US between 2000–2016, with falls accounting for 4.4% of all Medicare hospital expenditures and nearly 12% of spending for home health services and long-term care facilities(67). This reported increase in fall mortality fits the data described in this study, which reflect rising morbidity in the form of hospitalizations over ED-only encounters. Additionally, per Newgard et al, 2021, adults who experience non-fatal fall injuries have increased post-acute healthcare expenditures (median increase of $12,682), which is reflected in this study’s methodology of describing medical costs in the one-year period following injury(68). As to explanations behind increased incidence and associated costs of falls in the US, a rapidly-aging population is thought to be the main driver(18, 66, 69).
In a 2018 study that also used the CDC WISQARS database alongside the Medicare Current Beneficiaries Survey to analyze fall injury, Florence et al describe various characteristics of those experiencing non-fatal falls(18). The study reports significantly greater fall risk in elderly, female, Caucasian, and lower income adults, with additional risk posed by medical comorbidities including depression and diabetes(18). While there is substantial agreement across clinical practice guidelines on fall risk prevention and risk stratification, fall injuries are expected to continue increasing in coming years(64).
Unintentional motor vehicle injuries were found to be the second costliest non-fatal hospitalization and release injury and third costliest ED and release injury. In reverse order to motor vehicle injuries, unintentional struck by/against injuries were found to be the third costliest non-fatal hospitalization and release injury and second costliest ED and release injury. Despite sharing the same injury types across their top three costliest injuries, the rate of change in cost from 2015–2022 differed widely between the two non-fatal outcome categories; morbidity increases, which are reflected in this study’s findings of increased hospitalization and decreased ED-only costs for all top three injury types, are also demonstrated by the categories’ average cost change from 2015 (+ 26% hospitalization and release versus − 1% ED and release). This relative decline in ED and release injury incidence and costs persisted despite rebounds in 2021 and 2022 following the COVID-19 outbreak, trends exhibited by all three injury categories(6).
Short-term shifts in injury incidence due to the COVID-19 pandemic are characterized and discussed by He et al, 2022(6). He et al notes increased mortality but decreased morbidity in 2020(6), trends replicated and extended to 2022 in this study. The specific discrepancy in non-fatal hospitalization and ED trends are thought to be mainly due to delayed seeking of emergency care by patients and caretakers fearful of contracting COVID-19 from healthcare settings(6, 70, 71). Secondarily, healthcare resources may have also been re-prioritized and stretched to an extent that reduced and delayed accessibility to emergency care(72). Such delays in care may have also increased mortality of patients with severe injuries, leading to the growing fatality trends described in this study(73).
While this study characterizes broad incidence and cost trends in a variety of fatal and non-fatal injury types, the study was limited by lack of specificity around injury demographics and etiology. For instance, age and gender demographics were not included in this study, nor were any underlying injury causes (i.e. driving while impaired or speeding for motor vehicle injuries). Relatedly, injury type groupings by the CDC are subjective and also feature an “Other” type not detailed in this study. This study also does not hypothesize specific consequences of medical and non-medical injury expenditures, including their effect on health insurance premiums, economic productivity, and patients’ or families’ future quality of life. Finally, this study provides no public health prevention or management guidance for the injuries characterized.
Despite these limitations, the CDC WISQARS continues to be a reliable injury surveillance database with adaptable features and recent updates(74). Future studies in the injury cost and surveillance fields should use studies including this one to elucidate cost-effective prevention and management strategies. Additional research should also be performed to further characterize and potentially mitigate injury-related costs, particularly non-medical costs related to work and quality of life losses.